These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1102892)

  • 1. [Fundamental cardiac and vascular effects of Ca++-antagonistic coronary drugs].
    Fleckenstein A
    Med Klin; 1975 Oct; 70(42):1665-74. PubMed ID: 1102892
    [No Abstract]   [Full Text] [Related]  

  • 2. [The calcium-antagonistic fundamental effects of Verapamil on myocardial fibers and smooth muscle cells of the blood vessels].
    Fleckenstein A; Grün G; Byon KY
    Minerva Med; 1975 May; 66(38):1827-37. PubMed ID: 1128823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fundamental cardiovascular effects of the Ca++ antagonistic coronary drug fendiline (author's transl)].
    Fleckenstein A; Fleckenstein-Grün G; Byon YK
    Arzneimittelforschung; 1977; 27(3):562-71. PubMed ID: 577423
    [No Abstract]   [Full Text] [Related]  

  • 4. [Different sites of action of diltiazem, nifedipine and verapamil on the myocardium and aortic and coronary smooth muscles].
    Raddino R; Poli E; Manca C; Ceconi C; Ferrari R
    Cardiologia; 1986 Jan; 31(1):47-53. PubMed ID: 3742515
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro analysis of Ca-antagonistic effects of prenylamine as mechanisms for its cardiac actions.
    Hashimoto K; Nakagawa Y; Nabata H; Imai S
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):212-21. PubMed ID: 646520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium-antagonism, a new principle in coronary vasodilation].
    Grün G; Fleckenstein A
    Minerva Med; 1975 May; 66(38):1838-45. PubMed ID: 805387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of several calcium antagonists and dipyridamole in the isolated perfused guinea pig heart.
    Jolly SR; Menahan LA; Gross GJ
    Life Sci; 1980 Dec; 27(24):2339-46. PubMed ID: 7207022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Change in inotropic and chronotropic function of the heart and resistance of the coronary vessels during combined use of Ca2+ antagonists].
    Tkachenko BI; Kostko SZ; Katsenovich RA; Stepanova TG; Shil'kurt BL
    Biull Eksp Biol Med; 1991 Jun; 111(6):584-6. PubMed ID: 1893174
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].
    Fleckenstein A; Tritthart H; Döring HJ; Byon KY
    Arzneimittelforschung; 1972 Jan; 22(1):22-33. PubMed ID: 4259147
    [No Abstract]   [Full Text] [Related]  

  • 12. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of verapamil, gallopamil, diltiazem and nifedipine on sarcoplasmic reticulum function in rat heart.
    Zucchi R; Limbruno U; Ronca-Testoni S; Yu G; Galbani P; Ronca G; Mariani M
    Cardioscience; 1992 Sep; 3(3):167-72. PubMed ID: 1330045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of calcium-dependent action potentials in mammalian myocardium by specific inhibitors of the transmembrane calcium conductivity (verapamil, D 600).
    Tritthart H; Volkmann R; Weiss R; Fleckenstein A
    Recent Adv Stud Cardiac Struct Metab; 1975; 5():27-33. PubMed ID: 1188159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of calcium ion antagonism and beta-adrenergic blockade.
    Schlepper M
    Clin Invest Med; 1980; 3(1-2):9-12. PubMed ID: 6110500
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contents and role of adenosine in the heart and blood vessels].
    Czyzewicki T
    Pol Tyg Lek; 1971 Jun; 26(4):926-9. PubMed ID: 4948279
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contents and role of adenosine in the heart and blood vessels].
    Czyzewicki T
    Pol Tyg Lek; 1971 Jun; 26(4):926-9. PubMed ID: 4936842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.